Sale!

Noopept 20 mg – 60 capsules

Original price was: $49.00.Current price is: $45.00.

Noopept 20 mg — 60 oral research capsules. Noopept (N-phenylacetyl-L-prolylglycine ethyl ester, GVS-111) is the most extensively characterized member of the second-generation racetam-derived nootropic class. Originally developed and clinically registered in the Russian Federation, it is roughly 1,000-fold more potent on a per-milligram basis than the parent compound piracetam, with documented activity at concentrations as low as 10 nM. Its proximal active metabolite — cycloprolylglycine (CPG) — is itself a naturally occurring endogenous neuropeptide, a property unique among synthetic nootropics. The 20 mg per-capsule dose mirrors the standard clinical-research range used in published Russian-language clinical pharmacology.

 

RESEARCH USE ONLY  ·  Not for human or veterinary use. For laboratory and collector purposes only.

 

Purity
≥ 99 % (HPLC) — third-party tested, CoA on file
Form
Research capsules
Content
20 mg Noopept per capsule
Total
60 capsules per bottle (1.2 g total)
Packaging
Sealed bottle with tamper-evident closure
Storage
Room temperature, dry, protected from light
Molecular formula
C₁₇H₂₂N₂O₄
Molecular weight
≈ 318.37 g·mol⁻¹
IUPAC name
Ethyl 2-{[(2S)-1-(2-phenylacetyl)pyrrolidin-2-yl]carbonylamino}acetate
CAS number
157115-85-0
Synonyms
GVS-111; N-phenylacetyl-L-prolylglycine ethyl ester; Omberacetam

 

Research Overview

Noopept is a peptide-derived nootropic that crosses the blood–brain barrier rapidly after oral administration and is hydrolyzed to its endogenous active metabolite cycloprolylglycine (CPG), which is itself a naturally occurring brain neuropeptide [1,2]. In rodent models, Noopept reliably enhances performance in passive-avoidance, conditioned-fear and spatial-memory paradigms across a remarkably wide dose range, with documented effects on hippocampal LTP, NGF and BDNF expression, and cholinergic, glutamatergic and α-adrenergic signaling tone [1,2]. Russian-language clinical literature reports cognitive-improvement effects in mild cognitive impairment of vascular and post-traumatic origin, with the molecule registered for clinical use in the Russian Federation under the name Noopept since 2002 [3]. Across the published preclinical record, Noopept exhibits anxiolytic, neuroprotective and antioxidant activity in addition to its core nootropic phenotype, and is widely used as a tool compound in mechanistic studies of CPG-mediated neuropeptide signaling.

 

Primary Research Areas

  • Memory and learning research — consistent enhancement of acquisition, consolidation and retrieval in rodent paradigms; one of the most pharmacologically robust pro-cognitive tool compounds available [8].
  • BDNF / NGF and neurotrophic signaling — documented upregulation of brain neurotrophin expression, of interest in research on neuroplasticity and cognitive resilience [7].
  • Hippocampal LTP and synaptic plasticity — facilitates LTP induction and maintenance — the cellular substrate of declarative-memory consolidation [1,2].
  • Neuroprotection and ischemia models — evaluated in cerebral ischemia, hypoxic injury and neurodegeneration paradigms with reproducible protective signals [8].
  • Anxiolytic and stress-response research — probed in elevated-plus-maze, forced-swim and chronic-stress paradigms; the anxiolytic phenotype is dissociable from the cognitive phenotype [8].
  • Blood sugar in diabetic rats — in Wistar rats made diabetic with streptozotocin, Noopept raised the low blood levels of the gut hormone GLP-1 and of insulin back towards normal, and the glucose-lowering effect was stronger by mouth than by injection. It is rat work, with no human diabetes trial [1].
  • Swelling and inflammatory signals — single doses of 1-10 mg/kg damped acute inflammation in rats given carrageenan and in mice given concanavalin A, and five days of 5 mg/kg cut the inflammatory messenger IL-6 and halved TNF-alpha in mice injected with bacterial endotoxin. Diclofenac was the comparator; all of it is rodent work [2].
  • Thinner blood — over ten days of dosing, rats given 1 mg/kg by injection or 10 mg/kg by mouth showed slower clotting, faster clot breakdown and weaker fibrin stabilisation, and the metabolite cyclo-prolylglycine also blocked platelet clumping in the dish. The overlap with anticoagulant drugs has not been tested [3].
  • Harm when given to newborn rats — rat pups dosed under the skin on days 8 to 20 of life grew into adults that learned a six-arm maze worse, not better, on both declarative and procedural measures, and fewer males ever learned the task. It is a reason to keep this away from the young [4].
  • Supplement labels get it wrong — ten memory supplements bought online were analysed by mass spectrometry. One delivered up to 40.6 mg of omberacetam per serving against a typical 10 mg dose, several drugs found were absent from the label, and 9 of 12 declared quantities were inaccurate [5].
  • Work capacity in heat — healthy volunteers aged 20 to 24 were tested in a climate chamber under overcooling, overheating and low-pressure hypoxia; noopept helped them adapt to both hot and cold conditions, and in the heat it also raised physical work capacity. The report gives no group sizes [6].

 

References

  1. Ostrovskaya RU, Zolotov NN, Ozerova IV, et al. Noopept normalizes parameters of the incretin system in rats with experimental diabetes. Bull Exp Biol Med. 2014;157(3):344-9. PMID 25065315. doi:10.1007/s10517-014-2562-5
  2. Alekseeva SV, Kovalenko LP, Tallerova AV, et al. [An experimental study of the anti-inflammatory action of noopept and its effect on the level of cytokines]. Eksp Klin Farmakol. 2012;75(9):25-7. PMID 23156084.
  3. Ostrovskaia RU, Liapina LA, Pastorova VE, et al. [Multicomponent antithrombotic effect of the neuroprotective prolyl dipeptide GVS-111 and its major metabolite cyclo-L-prolylglycine]. Eksp Klin Farmakol. 2002;65(2):34-7. PMID 12109290.
  4. Trofimov SS, Voronina TA, Guzevatykh LS. Early postnatal effects of noopept and piracetam on declarative and procedural memory of adult male and female rats. Bull Exp Biol Med. 2005;139(6):683-7. PMID 16224581. doi:10.1007/s10517-005-0378-z
  5. Cohen PA, Avula B, Wang YH, et al. Five Unapproved Drugs Found in Cognitive Enhancement Supplements. Neurol Clin Pract. 2021;11(3):e303-e307. PMID 34484905. doi:10.1212/CPJ.0000000000000960
  6. Shabanov PD, Ganapol’skiĭ VP, Aleksandrov PV. [Meteoadaptogenic properties of peptide drugs in healthy volunteers]. Eksp Klin Farmakol. 2007;70(6):41-7. PMID 18318195.
  7. Ostrovskaya RU, Gudasheva TA, Zaplina AP, et al. Noopept stimulates the expression of NGF and BDNF in rat hippocampus. Bull Exp Biol Med. 2008;146(3):334-7. PMID 19240853. doi:10.1007/s10517-008-0297-x
  8. Ostrovskaia RU, Gudasheva TA, Voronina TA, et al. [The original novel nootropic and neuroprotective agent noopept]. Eksp Klin Farmakol. 2002;65(5):66-72. PMID 12596521.
Noopept (known generically as omberacetam) is a synthetic peptide and nootropic drug developed in Russia in 1996. It is promoted to boost memory, focus, and mental clarity, acting as a prodrug of cyclic glycine-proline that increases brain-derived neurotrophic factor (BDNF). [1, 2, 3, 4, 5]
How It Works
  • Neurotrophic Factors: Increases levels of BDNF and nerve growth factor (NGF) in the hippocampus, which supports brain cell health and neuroplasticity.

  • Receptor Modulation: Influences acetylcholine and AMPA/glutamate receptors to help with memory formation.

  • Neuroprotection: Helps protect brain cells from oxidative stress, inflammation, and excess calcium or glutamate toxicity. [1, 2, 3, 4, 5]

Legal and Medical Status

  • Russia & Neighboring Countries: Approved as a prescription medicine or drug for cognitive support and memory issues.

  • United States: Classified as an unapproved new drug by the FDA; it is not permitted to be sold as a dietary supplement.

  • Other Regions: Regulated or restricted in several countries (such as controlled in Hungary or prohibited for human consumption in the UK). [1, 2]

Evidence and Safety

  • Research Limitation: Most data supporting its effectiveness come from animal (rodent) studies, with very few small human clinical trials.

  • Side Effects: Reported side effects can include sleep disturbances, irritability, headaches, and elevated blood pressure. [1, 2, 3, 4]

Are you researching the pharmacology of nootropics, or are you looking into specific cognitive enhancement options?

Why Limitless Biochem Shop?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

Reviews

There are no reviews yet.

Be the first to review “Noopept 20 mg – 60 capsules”

Your email address will not be published. Required fields are marked *

Shopping Cart

Save to list